SANOFI SA Reports 4th Quarter Financials, Ending FY2022 on December 31, 2023.

March 26, 2023

Earnings Overview

On February 3 2023, SANOFI SA ($BER:SNW) revealed their fourth quarter financial results for the fiscal year closing December 31 2022, with a 29.2% rise in total revenues to EUR 1.5 billion and a 10.0% year-on-year increase in net income to EUR 11.5 billion.

Market Price

SANOFI SA, a global pharmaceuticals giant, has reported its 4th quarter financials, ending FY2022 on December 31, 2023. On Friday, SANOFI SA stock opened at €86.0 and closed at €86.0, down 3.2% from prior closing price of 88.9. The acquisition is expected to bring significant cost savings and synergies to SANOFI SA, paving the way for further growth in the coming years. Overall, the financial performance of SANOFI SA has been positive despite the unfavorable economic conditions of the past few years, and the company is well-positioned to capitalize on the opportunities that lie ahead in FY2023. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Sanofi Sa. More…

    Total Revenues Net Income Net Margin
    45.39k 8.37k 20.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Sanofi Sa. More…

    Operations Investing Financing
    10.53k -2.08k -5.82k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Sanofi Sa. More…

    Total Assets Total Liabilities Book Value Per Share
    126.72k 51.57k 56.58
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Sanofi Sa are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    6.4% 18.0% 24.0%
    FCF Margin ROE ROA
    18.3% 9.3% 5.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we have conducted an in-depth analysis of the financials of SANOFI SA. Our analysis of their financial and business aspects has determined they are a medium-risk investment. We have detected two risk warnings in the income sheet and balance sheet of SANOFI SA. To view our risk ratings and analysis in greater detail, be sure to register with us. Through our comprehensive analysis, you’ll be able to make more informed decisions when it comes to your investments. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Summary

    SANOFI SA reported strong earnings results for Q4 of FY 2022, with total revenue up 29.2% to EUR 1.5 billion and net income up 10.0% to EUR 11.5 billion. Despite this positive news, the company’s stock price dropped on the day of the earnings release. Investors may want to consider SANOFI SA as a long-term investment, given its solid financial performance and potential for further growth. A detailed analysis of the company’s fundamentals and how it fits within the broader industry should be conducted before making any investment decisions.

    Recent Posts

    Leave a Comment